Trends in the outcomes of Dutch haematological patients receiving intensive care support

Netherlands Journal of Medicine

Volumn 72, Issue 2, 2014, Pages 107-112

  van Vliet, M ^a   van der Burgt, M P E M ^a   van der Velden, W J F M ^a   van der Hoeven, J G ^a   de Haan, A F J ^a   Donnelly, J P ^a   Pickkers, P ^a   Blijlevens, N M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Haematological malignancy; Haematopoietic stem cell transplant; Intensive care unit admission; Outcome; Risk factors

Indexed keywords

CIPROFLOXACIN; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUDARABINE; HYPERTENSIVE AGENT; IDARUBICIN; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GENDER; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; WHOLE BODY RADIATION; DISEASE MANAGEMENT; EPIDEMIOLOGY; FOLLOW UP; HEMATOLOGIC DISEASES; HOSPITALIZATION; MIDDLE AGED; NETHERLANDS; PROGNOSIS; STATISTICS AND NUMERICAL DATA; TRENDS;

DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84895794063     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784-92.
2. Schattenberg AV, Schouten HC, Verdonck LF, et al. [Allogenic stem cell transplantation in the Netherlands]. Ned Tijdschr Geneeskd. 2009;153:380-5.
3. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091-101.
4. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 2003;31:104-12.
5. Ferra C, Marcos P, Misis M, et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol. 2007;85:195-202.
6. Soubani AO, Kseibi E, Bander JJ, et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest. 2004;126:1604-11.
7. Rhee CK, Kang JY, Kim YH, et al. Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies. Crit Care. 2009;13:R173.
8. Tack CJ, Santman FW. [Results of intensive care treatment in patients with hematologic malignancies; relation to infections]. Resultaten van intensive care-behandeling bij patienten met een hematologische maligniteit; het verband met infecties. Ned Tijdschrift Geneeskunde. 1992;136:25-9.
9. Souza-Dantas VC, Salluh JI, Soares M. Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case-control study. Ann Oncol. 2011;22:2094-100.
10. Pene F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;24:643-9.
11. Bokhari SW, Munir T, Memon S, Byrne JL, Russell NH, Beed M. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission. Ann Hematol. 2010;89:505-12.
12. Afessa B, Azoulay E. Critical care of the hematopoietic stem cell transplant recipient. Crit Ccare Clinics. 2010;26:133-50.
13. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344:481-7.
14. Gratwohl A, Stern M, Brand R, et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009;115:4715-26.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
16. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
17. Lim Z, Pagliuca A, Simpson S, Cottam S, Ervine M, Ho AY, et al. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. Br J Haematol. 2007;136:448-50.
18. Hayani O, Al-Beihany A, Zarychanski R, et al. Impact of critical care outreach on hematopoietic stem cell transplant recipients: a cohort study. Bone Marrow Transplant. 2011;46:1138-44.
19. Moran JL, Solomon PJ, for the ANZICS Centre for Outcome and Resource Evaluation of the Australian and New Zealand Intensive Care Society. Mortality and intensive care volume in ventilated patients from 1995 to 2009 in the Australian and New Zealand binational adult patient intensive care database*. Crit Care Med. 2012;40:800-12.
20. Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care. 2011;1:5.
21. Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 year study. Br J Anaesth. 2012;108:452-9.
22. Gilbert C, Vasu TS, Baram M. Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2013;19:321-4.
23. Squadrone V, Massaia M, Bruno B, et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med. 2010;36:1666-74.
24. Pene F, Soares M. Can we still refuse ICU admission of patients with hematological malignancies? Intensive Care Med. 2008;34:790-2.
25. van Vliet M, Potting CM, Sturm PD, Donnelly JP, Blijlevens NM. How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient. Eur J Cancer Care (Engl). 2011;20:679-85.
26. Depuydt P, Kerre T, Noens L, et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplant. 2011;46:1186-91.
27. Kim SW, Kami M, Urahama N, et al. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation. Transplantation. 2003;75:566-70.
28. Chang L, Horng CF, Huang YC, Hsieh YY. Prognostic accuracy of Acute Physiology and Chronic Health Evaluation II scores in critically ill cancer patients. Am J Crit Care. 2006;15:47-53.